Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Entecavir Monotherapy vs Combination with Adefovir in Chronic Hepatitis B
NCT01341743Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Dec 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of entecavir in Chronic Hepatitis B (CHB) (3 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Proportion of subjects with hepatitis B virus (HBV) DNA < 300 copies/ml at 104 weeks. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01341743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341743.